Research Article
Prevalence and Antimicrobial Susceptibility of Bacterial Uropathogens Isolated from Pediatric Patients at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia
Table 4
The number and percent of resistant strains of Gram-negative uropathogens among pediatric patients at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia, 2014.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AMP: augmentin (30 μg); NOR: norfloxacin (30 μg); GN: gentamicin (30 μg); CIP: ciprofloxacin (5 μg); NA: nalidixic acid (30 μg); F: nitrofurantoin (30 μg); CAZ: ceftazidime (30 μg); CTX: cefotaxim (30 μg); C: chloramphenicol (30 μg); SXT: trimethoprim-sulfamethoxazole (1.25/23.75 μg); CXM: cefuroxime (30 μg). |